Literature DB >> 29679695

Serial NSE measurement identifies non-survivors following out of hospital cardiac arrest.

Kieran Gillick1, Kieron Rooney2.   

Abstract

AIMS: Prognostication following out-of-hospital cardiac arrest (OHCA) remains challenging. A multimodal approach is favoured, including consideration of the biomarker neuron-specific enolase (NSE) (Sandroni et al., 2014). Our objective was to investigate the utility of serial NSE measurements and to determine an appropriate cut-off value for prediction of death before hospital discharge using data from our tertiary care center.
METHODS: Retrospective analysis of patients admitted to the critical care unit of a tertiary center critical care unit in the UK following an out-of-hospital cardiac arrest.
MEASUREMENTS AND MAIN RESULTS: We analysed data from 72 patients admitted to our unit over 8 months following out-of-hospital cardiac arrest. Initial NSE level (NSE0) was a poor predictor of outcome. Both NSE level at 48 h post-admission (NSE48) and change in NSE from baseline to 48 h post-admission (ΔNSE) were good predictors of outcome. A cut-off of NSE48 > 69.8 ng/ml gave a specificity of 1.00 and sensitivity of 0.62 for prediction of death before hospital discharge in our patient group, whilst a cut-off of ΔNSE > 31.3 ng/ml gave a specificity of 1.00 and sensitivity of 0.54. In patients who did not survive to hospital discharge, ΔNSE > 9.4 ng/ml was associated with other poor prognostic factors (asytolic/PEA arrest, long downtime before ROSC) and with more rapid deterioration before death.
CONCLUSION: Serial measurement of NSE levels (at 0 and 48 h after admission) provides a useful tool to aid prognostication following out-of-hospital cardiac arrest.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  NSE; OHCA; Prognostication

Mesh:

Substances:

Year:  2018        PMID: 29679695     DOI: 10.1016/j.resuscitation.2018.04.010

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  5 in total

Review 1.  The Influence of Therapeutics on Prognostication After Cardiac Arrest.

Authors:  Sachin Agarwal; Nicholas Morris; Caroline Der-Nigoghossian; Teresa May; Daniel Brodie
Journal:  Curr Treat Options Neurol       Date:  2019-11-25       Impact factor: 3.598

Review 2.  Neurological Prognostication After Cardiac Arrest in the Era of Target Temperature Management.

Authors:  Maximiliano A Hawkes; Alejandro A Rabinstein
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-09       Impact factor: 5.081

3.  Serial disseminated intravascular coagulation score with neuron specific enolase predicts the mortality of cardiac arrest-a pilot study.

Authors:  Qiangrong Zhai; Lu Feng; Hua Zhang; Meng Wu; Daidai Wang; Hongxia Ge; Shu Li; Langfang Du; Kang Zheng; Hui Li; Shaoyu Liu; Jingjing Zhao; Wei Huai; Qingbian Ma
Journal:  J Thorac Dis       Date:  2020-07       Impact factor: 3.005

4.  Peripheral Blood and Salivary Biomarkers of Blood-Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts.

Authors:  Damir Janigro; Damian M Bailey; Sylvain Lehmann; Jerome Badaut; Robin O'Flynn; Christophe Hirtz; Nicola Marchi
Journal:  Front Neurol       Date:  2021-02-04       Impact factor: 4.003

5.  Ultra-early serum concentrations of neuronal and astroglial biomarkers predict poor neurological outcome after out-of-hospital cardiac arrest-a pilot neuroprognostic study.

Authors:  Karl W Huesgen; Yasmeen O Elmelige; Zhihui Yang; Muhammad Abdul Baker Chowdhury; Sarah Gul; Carolina B Maciel; Marie-Carmelle Elie-Turenne; Torben K Becker; Scott A Cohen; Amy Holland; Cindy Montero; Tian Zhu; Kevin K Wang; Joseph A Tyndall
Journal:  Resusc Plus       Date:  2021-06-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.